Home · Safety · GLP-1 Contraindications

GLP-1 Contraindications: Who Should Not Take a GLP-1

What the FDA labels say, side by side.

Released: Last reviewed:

Short answer · November 8, 2026

Who should not take a GLP-1 for weight loss? The Wegovy, Zepbound and Foundayo labels list two contraindications: a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), and a serious hypersensitivity to the drug or its ingredients, and all three carry a boxed warning about thyroid C-cell tumors. The Wegovy label says to stop at least 2 months before a planned pregnancy. Zepbound and Foundayo can make oral contraceptives less reliable, so their labels advise a non-oral or added barrier method after starting and after each dose increase. Compounded versions have no FDA label.

Contraindications and key label cautions (FDA labels read November 8, 2026)
Label itemWegovy (injection and tablets)ZepboundFoundayo
ContraindicationsPersonal or family history of MTC or MEN 2; prior serious hypersensitivity to semaglutide or excipientsPersonal or family history of MTC or MEN 2; known serious hypersensitivity to tirzepatide or excipientsPersonal or family history of MTC or MEN 2; known serious hypersensitivity to orforglipron or excipients
Boxed warningRisk of thyroid C-cell tumorsRisk of thyroid C-cell tumorsRisk of thyroid C-cell tumors (class-based)
PregnancyStop when pregnancy is recognized; stop at least 2 months before a planned pregnancyStop when pregnancy is recognizedStop when pregnancy is recognized
Oral contraceptivesNo label instructionSwitch to non-oral or add a barrier method for 4 weeks after starting and after each dose increaseSwitch to non-oral or add a barrier method for 30 days after starting and after each dose increase
Missed doseInjection: take if the next dose is more than 2 days away; tablets: skip and take the next dayTake within 4 days (96 hours), otherwise skipTake as soon as possible; do not double up

Other reasons to talk to your clinician first

The labels list warnings rather than outright bans for a history of pancreatitis, gallbladder disease, kidney problems, diabetic retinopathy, and planned surgery with anesthesia or deep sedation (risk of pulmonary aspiration). If you take insulin or a sulfonylurea, the hypoglycemia risk is higher and doses may need to change.

Online programs and screening

A telehealth program should ask about thyroid cancer history, MEN 2, pregnancy plans and past pancreatitis before prescribing. If the intake does not ask, treat that as a warning sign; see our scam checker. Compounded semaglutide and tirzepatide have no FDA label of their own, so prescribers rely on the brand labels for these cautions. See also side effects, side-effect rates compared across the labels and drug interactions.

FAQ

Who should not take a GLP-1 for weight loss?

The Wegovy, Zepbound and Foundayo labels list two contraindications: a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), and a serious hypersensitivity to the drug or its ingredients, and all three carry a boxed warning about thyroid C-cell tumors. The Wegovy label says to stop at least 2 months before a planned pregnancy. Zepbound and Foundayo can make oral contraceptives less reliable, so their labels advise a non-oral or added barrier method after starting and after each dose increase. Compounded versions have no FDA label.

Can I take a GLP-1 if a relative had thyroid cancer?

It depends on the type. The labels contraindicate GLP-1s for people with a personal or family history of medullary thyroid carcinoma (MTC) or MEN 2. Other thyroid cancers are not listed as contraindications, but tell your clinician about any thyroid history.

Do GLP-1s affect birth control pills?

The Zepbound label says it may reduce the effect of oral hormonal contraceptives and advises a non-oral method or an added barrier method for 4 weeks after starting and after each dose increase; the Foundayo label says 30 days. The Wegovy label has no such instruction.

What if I am planning a pregnancy?

The Wegovy label says to stop at least 2 months before a planned pregnancy. The Zepbound and Foundayo labels say to stop when a pregnancy is recognized. Talk to your clinician before trying to conceive.

Does the boxed warning mean GLP-1s cause thyroid cancer?

The warning comes from rodent studies; the labels say it is unknown whether these drugs cause thyroid C-cell tumors, including MTC, in humans. For Foundayo the warning is based on the drug class. People with MTC or MEN 2 history should not take them.

Sources

  1. DailyMed — Wegovy (semaglutide) injection and tablets prescribing information, revised 06/2026 (read November 8, 2026)
  2. DailyMed — Zepbound (tirzepatide) prescribing information, revised 08/2026 (read November 8, 2026)
  3. DailyMed — Foundayo (orforglipron) prescribing information, revised 07/2026 (read November 8, 2026)
Researched By
Dr. Parmis
Medical Researcher · Western University of Health Sciences
Medically Reviewed By
Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)
Last medically reviewed: November 8, 2026 · This page is informational and does not constitute medical advice.